Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The goal of the project is to develop five to ten promising and tested new compounds for fighting multidrug-resistant infection caused by staph and related microbes, including vancomycin-resistant Enterococcus. The five-year project will be led by Michael Gilmore, PhD.
Related Articles on Antibiotic-Resistant Bacteria:
Most Hospital Uniforms Carry Bacteria, Study Shows
Tennessee Hospitals Improve Quality, Infection Control
New Bill Would Require Facility-Wide Plan From New Jersey Hospitals to Prevent Spread of MRSA
